Skip to main navigation Skip to search Skip to main content

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension

Susan P Mollan*, Clare L Fraser, Kathleen B Digre, Hans-Christoph Diener, Richard B Lipton, Marianne Juhler, Neil R Miller, Patricia Pozo-Rosich, Mansoureh Togha, Kristian Brock, Marc J Dinkin, Carmen K M Chan, Cristina Tassorelli, Alex J Sinclair, Gisela M Terwindt, Rigmor H Jensen

*Corresponding author for this work
16 Citations (Scopus)

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

Original languageEnglish
Article number3331024231197118
JournalCephalalgia : an international journal of headache
Volume43
Issue number8
ISSN0333-1024
DOIs
Publication statusPublished - Aug 2023

Keywords

  • Humans
  • Pseudotumor Cerebri/therapy
  • Headache/therapy
  • Pseudotumor cerebri
  • lumbar puncture
  • papilloedema
  • drug
  • Guidelines
  • vision
  • raised intracranial pressure
  • Idiopathic intracranial hypertension
  • Randomised control trial
  • headache

Fingerprint

Dive into the research topics of 'Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension'. Together they form a unique fingerprint.

Cite this